Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsAddiction psychiatry — nicotine and behavioural addictions

Psych · Addiction psychiatry — nicotine and behavioural addictions

Nicotine and behavioural addictions

Also known as Tobacco use disorder · Nicotine dependence · Smoking cessation · Varenicline · NRT · Gambling disorder · Pathological gambling · Gaming disorder · Internet gaming disorder · Behavioural addiction

Exam-exhaustive fellowship reference on nicotine/tobacco use disorder (FTND, combination NRT, varenicline, bupropion, e-cigarettes, EAGLES, dual diagnosis with SMI), gambling disorder, and gaming/internet-use disorders (ICD-11 vs DSM-5-TR). FRANZCP-primary, globally tagged.

medium22 referencesUpdated 26 July 202614 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Therapeutic nihilism about smoking in severe mental illness — smoking drives a large share of excess mortality; offer full cessation care
  • Gambling crisis with debt and suicidal ideation — risk assessment, safety plan, financial safeguards; do not treat as mere lifestyle issue
  • Bupropion in seizure risk, current eating disorder, or abrupt alcohol/benzodiazepine withdrawal — contraindicated or high-risk
  • Dopamine agonist-induced impulse control (gambling, hypersexuality, shopping) in Parkinson disease or restless legs — review neurology medication, not only 'primary addiction'
  • Ward smoke-free policy without proactive NRT — under-treatment fuels agitation and inequity
  • Pathologising all heavy gaming without functional impairment, or missing ADHD/autism/mania differentials
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Therapeutic nihilism about smoking in severe mental illness — smoking drives a large share of excess mortality; offer full cessation care
  • Gambling crisis with debt and suicidal ideation — risk assessment, safety plan, financial safeguards; do not treat as mere lifestyle issue
  • Bupropion in seizure risk, current eating disorder, or abrupt alcohol/benzodiazepine withdrawal — contraindicated or high-risk
  • Dopamine agonist-induced impulse control (gambling, hypersexuality, shopping) in Parkinson disease or restless legs — review neurology medication, not only 'primary addiction'
  • Ward smoke-free policy without proactive NRT — under-treatment fuels agitation and inequity
  • Pathologising all heavy gaming without functional impairment, or missing ADHD/autism/mania differentials
One-line fellowship answer

Treat tobacco use disorder with brief advice plus behavioural support and pharmacotherapy — prefer combination NRT or varenicline (EAGLES supports neuropsychiatric safety), not therapeutic nihilism in severe mental illness; treat gambling disorder with CBT or MI, financial safeguards and suicide-risk work, with naltrexone only a selected adjunct; diagnose gaming disorder carefully (ICD-11 impairment threshold; DSM-5-TR Section III research criteria) and treat comorbidity rather than moral panic.[1][6][11][16]

Meet the patient

A 47-year-old man with schizophrenia is admitted under the psychiatry team. He smokes forty a day, lights up within two minutes of waking, and has never been offered cessation treatment. The ward is smoke-free, and by evening he is irritable, tremulous, and refusing to engage — labelled in the handover as "behavioural."[14][21]

He is not behavioural. He is in untreated nicotine withdrawal on a ward that forgot his NRT. Tobacco is the leading modifiable cause of early death in severe mental illness, and the "they need cigarettes to cope" line is not a treatment plan.[1][21]

This topic covers three exam pillars in one place: tobacco and nicotine, gambling disorder, and gaming and internet-use problems — framed so you neither over-pathologise a hobby nor miss a genuine disorder.[16][18]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References22ShowHide
  1. [1]Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial Lancet, 2016.PMID 27116918
  2. [2]Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial JAMA, 2006.PMID 16820546
  3. [3]Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA, 2006.PMID 16820547
  4. [4]Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial JAMA, 2006.PMID 16820548
  5. [5]Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T Nicotine receptor partial agonists for smoking cessation Cochrane Database Syst Rev, 2016.PMID 27158893
  6. [6]Cahill K, Stevens S, Perera R, Lancaster T Pharmacological interventions for smoking cessation: an overview and network meta-analysis Cochrane Database Syst Rev, 2013.PMID 23728690
  7. [7]Theodoulou A, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation Cochrane Database Syst Rev, 2023.PMID 37335995
  8. [8]Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T Antidepressants for smoking cessation Cochrane Database Syst Rev, 2014.PMID 24402784
  9. [9]Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire Br J Addict, 1991.PMID 1932883
  10. [10]Grant JE, Kim SW, Hartman BK A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges J Clin Psychiatry, 2008.PMID 18384246
  11. [11]Hodgins DC, Stea JN, Grant JE Gambling disorders Lancet, 2011.PMID 21600645
  12. [12]Cowlishaw S, Merkouris S, Dowling N, Anderson C, Jackson A, Thomas S Psychological therapies for pathological and problem gambling Cochrane Database Syst Rev, 2012.PMID 23152266
  13. [13]Dowling N, Merkouris S, Lubman D, Thomas S, Bowden-Jones H, Cowlishaw S Pharmacological interventions for the treatment of disordered and problem gambling Cochrane Database Syst Rev, 2022.PMID 36130734
  14. [14]Tsoi DT, Porwal M, Webster AC Interventions for smoking cessation and reduction in individuals with schizophrenia Cochrane Database Syst Rev, 2013.PMID 23450574
  15. [15]Evins AE, Cather C Effective Cessation Strategies for Smokers with Schizophrenia Int Rev Neurobiol, 2015.PMID 26472528
  16. [16]Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, et al. An international consensus for assessing internet gaming disorder using the new DSM-5 approach Addiction, 2014.PMID 24456155
  17. [17]Brand M, Young KS, Laier C, Wölfling K, Potenza MN Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model Neurosci Biobehav Rev, 2016.PMID 27590829
  18. [18]Grant JE, Potenza MN, Weinstein A, Gorelick DA Introduction to behavioral addictions Am J Drug Alcohol Abuse, 2010.PMID 20560821
  19. [19]Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T Physician advice for smoking cessation Cochrane Database Syst Rev, 2013.PMID 23728631
  20. [20]Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R, et al. Electronic cigarettes for smoking cessation Cochrane Database Syst Rev, 2024.PMID 38189560
  21. [21]Williams JM, Ziedonis D Addressing tobacco among individuals with a mental illness or an addiction Addict Behav, 2004.PMID 15236808
  22. [22]Rigotti NA Strategies to help a smoker who is struggling to quit JAMA, 2012.PMID 23073954

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousNeurotransmitters, receptors and signallingFoundations — neurotransmitters receptors signallingNextOpioid substitution therapy and withdrawalAddiction psychiatry — substance use disorders